The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

63.44 0.98 −1.52%
Market cap
$12.1B
P/E
21.7×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a

The Cooper Companies, Inc. 10-K filed Dec 6, 2024

Fiscal year 2024 · Period ended Oct 31, 2024 · Filed · accepted 4:21 PM ET · Document on sec.gov · Filing index

Red flags

  • Auditor’s opinion

    The Cooper Companies, Inc.’s auditor’s report on its 10-K is not a clean opinion, or points to a restatement

    We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of October 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated December 6, 2024 expressed an adverse opinion on the effectiveness of the Company's internal control over financial reporting.

    10-K filed · The filing · sec.gov